Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Abbott Laboratories stock
Learn how to easily invest in Abbott Laboratories stock.
Abbott Laboratories is a medical devices business based in the US. Abbott Laboratories shares (ABT) are listed on the NYSE and all prices are listed in US Dollars. Abbott Laboratories employs 109,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Abbott Laboratories
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – ABT – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- ABT shares summary
- Compare share dealing platforms
- Is ABT stock a buy or sell?
- Stock performance over time
- Is ABT suitable for ethical investing?
- Are ABT shares over-valued?
- Abbott Laboratories's financials
- How volatile are ABT shares?
- Does Abbott Laboratories pay a dividend?
- Have ABT shares ever split?
- Other common questions
Abbott Laboratories stock price (NYSE: ABT)Use our graph to track the performance of ABT stocks over time.
Abbott Laboratories shares at a glance
|Latest market close||$125.83|
|52-week range||$104.19 - $142.10|
|50-day moving average||$132.25|
|200-day moving average||$123.07|
|Wall St. target price||$145.18|
|Dividend yield||$1.8 (1.45%)|
|Earnings per share (TTM)||$4.03|
Buy Abbott Laboratories shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Abbott Laboratories stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Abbott Laboratories price performance over time
|1 week (2022-01-14)||-1.82%|
|1 month (2021-12-22)||-9.47%|
|3 months (2021-10-18)||N/A|
|6 months (2021-07-22)||6.41%|
|1 year (2021-01-22)||11.51%|
|2 years (2020-01-22)||36.98%|
|3 years (2019-01-22)||76.01%|
|5 years (2017-01-20)||211.00%|
Is Abbott Laboratories stock undervalued or overvalued?
Valuing Abbott Laboratories stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Abbott Laboratories's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Abbott Laboratories's P/E ratio
Abbott Laboratories's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 32x. In other words, Abbott Laboratories shares trade at around 32x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Abbott Laboratories's PEG ratio
Abbott Laboratories's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.6196. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Abbott Laboratories's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Abbott Laboratories's EBITDA
Abbott Laboratories's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $12.4 billion.
The EBITDA is a measure of a Abbott Laboratories's overall financial performance and is widely used to measure a its profitability.
Abbott Laboratories financials
|Revenue TTM||$42.3 billion|
|Operating margin TTM||20.91%|
|Gross profit TTM||$19.6 billion|
|Return on assets TTM||7.74%|
|Return on equity TTM||21.86%|
|Market capitalisation||$226.6 billion|
TTM: trailing 12 months
Abbott Laboratories's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Abbott Laboratories.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Abbott Laboratories's total ESG risk score
Total ESG risk: 32.35
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Abbott Laboratories's overall score of 32.35 (as at 12/31/2018) is pretty weak – landing it in it in the 61st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Abbott Laboratories is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Abbott Laboratories's environmental score
Environmental score: 3.98/100
Abbott Laboratories's environmental score of 3.98 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Abbott Laboratories is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Abbott Laboratories's social score
Social score: 20.71/100
Abbott Laboratories's social score of 20.71 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Abbott Laboratories is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Abbott Laboratories's governance score
Governance score: 13.15/100
Abbott Laboratories's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Abbott Laboratories is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Abbott Laboratories's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Abbott Laboratories scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Abbott Laboratories hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||32.35|
|Total ESG percentile||60.66|
|Environmental score percentile||5|
|Social score percentile||5|
|Governance score percentile||5|
|Level of controversy||3|
Abbott Laboratories share dividends
Dividend payout ratio: 34.08% of net profits
Recently Abbott Laboratories has paid out, on average, around 34.08% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.45% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Abbott Laboratories shareholders could enjoy a 1.45% return on their shares, in the form of dividend payments. In Abbott Laboratories's case, that would currently equate to about $1.8 per share.
While Abbott Laboratories's payout ratio might seem fairly standard, it's worth remembering that Abbott Laboratories may be investing much of the rest of its net profits in future growth.
Abbott Laboratories's most recent dividend payout was on 14 February 2022. The latest dividend was paid out to all shareholders who bought their shares by 12 January 2022 (the "ex-dividend date").
Have Abbott Laboratories's shares ever split?
Abbott Laboratories's shares were split on a 10000:4798 basis on 1 January 2013. So if you had owned 4798 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Abbott Laboratories shares – just the quantity. However, indirectly, the new 52% lower share price could have impacted the market appetite for Abbott Laboratories shares which in turn could have impacted Abbott Laboratories's share price.
Abbott Laboratories share price volatility
Over the last 12 months, Abbott Laboratories's shares have ranged in value from as little as $104.1892 up to $142.0988. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Abbott Laboratories's is 0.7035. This would suggest that Abbott Laboratories's shares are less volatile than average (for this exchange).
Abbott Laboratories overview
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. It has collaboration agreement with Cereno Scientific AB (publ).
Abbott Laboratories in the news
Stocks To Watch: FOMC Meeting, Earnings Rush And Testing Times In Crypto
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Abbott Laboratories: Shelter Your Capital With This SWAN Stock
Frequently asked questionsWhat percentage of Abbott Laboratories is owned by insiders or institutions?
Currently 0.728% of Abbott Laboratories shares are held by insiders and 75.377% by institutions. How many people work for Abbott Laboratories?
Latest data suggests 109,000 work at Abbott Laboratories. When does the fiscal year end for Abbott Laboratories?
Abbott Laboratories's fiscal year ends in December. Where is Abbott Laboratories based?
Abbott Laboratories's address is: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400 What is Abbott Laboratories's ISIN number?
Abbott Laboratories's international securities identification number is: US0028241000 What is Abbott Laboratories's CUSIP number?
Abbott Laboratories's Committee on Uniform Securities Identification Procedures number is: 002824100
More guides on Finder
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Dogecoin jumps 10% on word you can use it to buy Tesla merch
While there are no known plans to expand the acceptance of Doge to its cars, customers can already buy a Tesla with Bitcoin.
Thursday’s top U.S. stocks: Taiwan Semiconductor Manufacturing Company Ltd. (TSM ↑8.4%), Lam Research Corporation (LRCX ↑6.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Is Berkshire Hathaway the next $1 trillion stock?
Buffett’s Berkshire Hathaway may now be on its way to becoming the next trillion-dollar company.
Tesla roars into 2022 after December drop
Record vehicle deliveries cause the Tesla stock price to move close to all-time highs.
How to buy Affinia Therapeutics (AFTX) stock when it goes public
Everything we know about the Affinia Therapeutics IPO, plus information on how to buy in.
Ask an Expert